ArticleMediastinum (Hong Kong, China)2019

Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk?

Chen Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.